AMBS' CEO responded to my questions and concerns about the recent dramatic drop in PPS, less than two hours after I sent my email last night. It's gratifying to know our CEO is sharp and caring enough to feel that timely responses to shareholder questions and concerns is important.
Whether I am long or short AMBS has no bearing on the integrity and dedication of the CEO. Whether or not AMBS becomes successful and profitable does depend in large part on those qualities. I am just very satisfied that our CEO has those positive qualities and strengths. PPS will rise and fall, being manipulated by MMs and affected by pumpers, dumpers, news, etc. But, overall, PPS will rise. That growth in PPS will be a reflection of the realization of the hope expressed by MJ Fox on Letterman last night, when he said that medical solutions to Parkinson's are in the works right now, with one of the most promising being the development of biomarkers, which is one of AMBS' fortes. He also said that his foundation is especially involved in assisting companies grow a medical treatment or cure for Parkinson's from idea to reality by expediting the process and getting the product into the pipeline. MJF was very excited about his current, successful treatment and said he looks forward to the time in the near future when other Parkinson's patients have the same successful treatment he has had, which treatment will continue to improve his (and their) condition. Letterman was encouraging and supportive of MJF, Parkinson's patients, and the search for a cure.
Was AMBS mentioned? Of course not. Neither was any other company. But, the use of biomarkers and genetics to diagnose and treat PD was discussed.